Evidence map›Paper›PMID 42404115›Full record

ArticleFrontiers in neurology

Hamid Mansouri, Nedim Gulkaya, Matthew J Gounis, Mohammad AlMajali, Amit Chaudhari, Darwin G Ramirez Abreu, Syed F Zaidi, Yazan K Ashouri, Naoki Kaneko, Brian T Jankowitz and 9 more

Abstract read
In one paragraph

Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Hamid MansouriDepartment of Mechanical, Industrial, and Manufacturing Engineering, University of Toledo, Toledo, OH, United States.
Nedim GulkayaGalaxy Therapeutics Inc., Milpitas, CA, United States.
Matthew J GounisDepartment of Radiology, University of Massachusetts Chan Medical School, Worcester, MA, United States.
Mohammad AlMajaliMercy Health Neuroscience Institute, Neurology and Neurosurgery, Toledo, OH, United States.
Amit ChaudhariMercy Health Neuroscience Institute, Neurology and Neurosurgery, Toledo, OH, United States.
Darwin G Ramirez AbreuMercy Health Neuroscience Institute, Neurology and Neurosurgery, Toledo, OH, United States.
Syed F ZaidiDepartment of Neurology, University of Toledo, Toledo, OH, United States.
Yazan K AshouriMercy Health Neuroscience Institute, Neurology and Neurosurgery, Toledo, OH, United States.
Naoki KanekoWestwood Imaging Center & Interventional Radiology Clinic, Los Angeles, CA, United States.
Brian T JankowitzHackensack Meridian Neuroscience Institute at JFK University Medical Center, Edison, NJ, United States.
David J AltschulMontefiore Einstein Advanced Care Neurosurgery, Elmsford, NY, United States.
Boris PabonCentro Comercial Cauca Centro, Universidad de Antioquia, Antioquia, Colombia.
Pervinder BhogalDepartment of Interventional Neuroradiology, The Royal London Hospital, Barts NHS Trust, London, United Kingdom.
Thomas J WolfeAurora Neuroscience Innovation, Milwaukee, WI, United States.
Edgard L PereiraNeuro Endovascular Surgery, McLeod Medical Center, Florence, SC, United States.
Aamir BadruddinPowers Health Medical Group, Neurosurgery and Spinal Surgery, Munster, IN, United States.
Laila IbrahimGalaxy Therapeutics Inc., Milpitas, CA, United States.
Omid AmiliDepartment of Mechanical, Industrial, and Manufacturing Engineering, University of Toledo, Toledo, OH, United States.
Osama O ZaidatMercy Health Neuroscience Institute, Neurology and Neurosurgery, Toledo, OH, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Intrasaccular devices such as SEAL™ and WEB™-SL are designed to disrupt aneurysmal flow. We present a new Methods: Particle image velocimetry (PIV) method was used in a patient-specific middle cerebral artery (MCA) wide-neck bifurcation aneurysm (WNBA) model to measure velocity, residence time (RT), and vorticity strength (VS). Tested devices included 3 each of SEAL-BASE (6 × 2 mm), SEAL-ARC (6 × 5 mm), and WEB-SL (6 × 4 mm). Results: Twelve experiments were performed (3 unique devices per size and 3 controls); the mean RT was 0.042 ± 0.006 s (control) and increased with SEAL-BASE (0.387 ± 0.128), SEAL-ARC (0.33 ± 0.092), and WEB-SL (0.171 ± 0.034) (all Conclusion: Both SEAL configurations achieved greater flow reduction compared to the WEB-SL of similar width in the same aneurysm model. Results highlight the unique utilization of the PIV method for the mechanistic decoupling of momentum transfer into the aneurysm sac resulting from intra-aneurysmal mesh structures and point toward their potential for further neurointerventional device optimization.

Indexed as

aneurysmintrasaccular devicesin vitro PIVpatient-specificSEAL and WEB

Identifiers

PMID42404115
PMCPMC13327948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.